[CDK4/6 inhibitors: biomarkers, mechanisms of resistance and interest of the study of the circulating tumor DNA].

Related Articles

[CDK4/6 inhibitors: biomarkers, mechanisms of resistance and interest of the study of the circulating tumor DNA].

Bull Cancer. 2018 May 02;:

Authors: Gonçalves A

PMID: 29729807 [PubMed - as supplied by publisher]

from Cancer via ola Kala on Inoreader https://ift.tt/2HYMOKw
via IFTTT